Journal
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY
Volume 19, Issue 2, Pages 179-185Publisher
SOC CARDIOLOGY RUSSIAN FEDERAT
DOI: 10.20996/1819-6446-2023-03-06
Keywords
Rendu-Osler syndrome; hereditary hemorrhagic telangiectasia; pulmonary hypertension; congestive heart failure
Categories
Ask authors/readers for more resources
A 64-year-old female with a family history of hereditary hemorrhagic telangiectasia (HHT) presented with dyspnea and leg edema. Despite treatment, her heart failure worsened after each episode of massive blood loss. Echocardiography revealed high pulmonary hypertension. Interstitial lung lesions were detected on CT scan. The patient's condition improved with cardiotropic and diuretic therapy, but she ultimately died from acute progression of pulmonary hypertension. Timely diagnosis and treatment of pulmonary hypertension in HHT are crucial for prognosis.
A 64-year-old female with a family history of hereditary hemorrhagic telangiectasia (HHT) was hospitalized due to complaints of dyspnea during light physical exertion and leg edema. HHT was diagnosed at 20 y.o., recurrent nasal bleeding started at age 52, bleedings severity was aggravated by not completely compensated hypertension. At the age of 60, after a massive hemorrhage, she noted the onset of dyspnea, edema, ascites. Diuretics and iron preparations improved her well-being, but from that period onward her heart failure worsened after each massive blood loss. The last major bleeding was before the present hospitalization (Hgb 67 g/l), after which heart failure symptoms significantly deteriorated. Echocardiography showed preserved left ventricular ejection fraction, but revealed high pulmonary hypertension (systolic pulmonary artery pressure 69 mmHg). Chest computed tomography (CT) with contrast showed no evidence of pulmonary embolism, but interstitial lung lesions were detected. Pulse therapy with glucocorti-costeroids did not result in positive dynamics at the control CT scan, which allowed to reject a separate interstitial lung disease. As a result of cardiotropic and diuretic therapy, as well as correction of anemia, the patient's condition improved. Macitentan was administered, but the patient refused from it because one of possible side effects was anemia. A year later the patient diedfrom acute progression of pulmonary hypertension. According to the literature, pulmonary hypertension in HHT can have a significant impact on the prognosis and requires timely diagnosis and treatment. Interstitial lung lesions are a manifestation of the underlying disease and does not require special treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available